Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 21586 AL 21600

A new interpretative paradigm for Conformational Protein Diseases

Agnati LF, Guidolin D, Woods AS, Ciruela F, Carone C, Vallelunga A, Escuela DO, Genedani S, Fuxe K.

Curr Protein Pept Sci. 2013 Mar;14(2):141-60. doi: 10.2174/1389203711314020006.

Transcranial magnetic stimulation of degenerating brain: a comparison of normal aging, Alzheimer's, Parkinson's and Huntington's disease

Ljubisavljevic MR, Ismail FY, Filipovic S.

Curr Alzheimer Res. 2013 Jul;10(6):578-96. doi: 10.2174/15672050113109990133.

Neuroimaging biomarkers of neurodegenerative diseases and dementia

Risacher SL, Saykin AJ.

Semin Neurol. 2013 Sep;33(4):386-416. doi: 10.1055/s-0033-1359312. Epub 2013 Nov 14.

Latrepirdine: molecular mechanisms underlying potential therapeutic roles in Alzheimer's and other neurodegenerative diseases

Bharadwaj PR, Bates KA, Porter T, Teimouri E, Perry G, Steele JW, Gandy S, Groth D, Martins RN, Verdile G.

Transl Psychiatry. 2013 Dec 3;3(12):e332. doi: 10.1038/tp.2013.97.

Animal models of neurodegenerative diseases

Ribeiro FM, Camargos ER, de Souza LC, Teixeira AL.

Braz J Psychiatry. 2013;35 Suppl 2:S82-91. doi: 10.1590/1516-4446-2013-1157.

Presenilin-1 mutations in Alzheimer's disease: an update on genotype-phenotype relationships

Larner AJ.

J Alzheimers Dis. 2013;37(4):653-9. doi: 10.3233/JAD-130746.

Contribution of brain imaging to the understanding of gait disorders in Alzheimer's disease: a systematic review

Annweiler C, Beauchet O, Celle S, Roche F, Annweiler T, Allali G, Bartha R, Montero-Odasso M; WALK Team (Working group Angers-London for Knowledge).

Am J Alzheimers Dis Other Demen. 2012 Sep;27(6):371-80. doi: 10.1177/1533317512454710.

Comparison of clinical characteristics between familial and non-familial early onset Alzheimer's disease

Karve SJ, Ringman JM, Lee AS, Juarez KO, Mendez MF.

J Neurol. 2012 Oct;259(10):2182-8. doi: 10.1007/s00415-012-6481-y. Epub 2012 Mar 30.

Autosomal dominant Alzheimer's disease with early frontal lobe involvement associated with the Met239Ile mutation of Presenilin 2 gene

Testi S, Fabrizi GM, Pompanin S, Cagnin A.

J Alzheimers Dis. 2012;31(1):7-11. doi: 10.3233/JAD-2012-120280.

Phenotypic profile of early-onset familial Alzheimer's disease caused by presenilin-1 E280A mutation

Sepulveda-Falla D, Glatzel M, Lopera F.

J Alzheimers Dis. 2012;32(1):1-12. doi: 10.3233/JAD-2012-120907.

Differential putaminal morphology in Huntington's disease, frontotemporal dementia and Alzheimer's disease

Looi JC, Rajagopalan P, Walterfang M, Madsen SK, Thompson PM, Macfarlane MD, Ching C, Chua P, Velakoulis D.

Aust N Z J Psychiatry. 2012 Dec;46(12):1145-58. doi: 10.1177/0004867412457224. Epub 2012 Sep 18.

Impact of genetic risk assessment on nutrition-related lifestyle behaviours

Vernarelli JA.

Proc Nutr Soc. 2013 Feb;72(1):153-9. doi: 10.1017/S0029665112002741. Epub 2012 Oct 25.

Cervical dystonia in an Alzheimer's disease patient treated with donepezil

Yagi Y, Watanabe Y, Yokote H, Amino T, Kamata T.

Acta Neurol Belg. 2013 Sep;113(3):363-4. doi: 10.1007/s13760-012-0143-9. Epub 2012 Oct 11.

N-methyl D-aspartate (NMDA) receptor antagonists and memantine treatment for Alzheimer's disease, vascular dementia and Parkinson's disease

Olivares D, Deshpande VK, Shi Y, Lahiri DK, Greig NH, Rogers JT, Huang X.

Curr Alzheimer Res. 2012 Jul;9(6):746-58. doi: 10.2174/156720512801322564.

Mild cognitive impairment associated with underlying Alzheimer's disease versus Lewy body disease

Boeve BF.

Parkinsonism Relat Disord. 2012 Jan;18 Suppl 1:S41-4. doi: 10.1016/S1353-8020(11)70015-3.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias